JP2002530420A - 平滑筋細胞増殖の阻害薬としてのベンジルマルトトリオシド - Google Patents

平滑筋細胞増殖の阻害薬としてのベンジルマルトトリオシド

Info

Publication number
JP2002530420A
JP2002530420A JP2000583923A JP2000583923A JP2002530420A JP 2002530420 A JP2002530420 A JP 2002530420A JP 2000583923 A JP2000583923 A JP 2000583923A JP 2000583923 A JP2000583923 A JP 2000583923A JP 2002530420 A JP2002530420 A JP 2002530420A
Authority
JP
Japan
Prior art keywords
carbon atoms
carbons
hydrogen
independently
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000583923A
Other languages
English (en)
Japanese (ja)
Inventor
ポール・ジェフリー・ドリングズ
Original Assignee
アメリカン・ホーム・プロダクツ・コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アメリカン・ホーム・プロダクツ・コーポレイション filed Critical アメリカン・ホーム・プロダクツ・コーポレイション
Publication of JP2002530420A publication Critical patent/JP2002530420A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08—Polyoxyalkylene derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2000583923A 1998-11-24 1999-11-23 平滑筋細胞増殖の阻害薬としてのベンジルマルトトリオシド Pending JP2002530420A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19880598A 1998-11-24 1998-11-24
US09/198,805 1998-11-24
PCT/US1999/027775 WO2000031095A2 (en) 1998-11-24 1999-11-23 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation

Publications (1)

Publication Number Publication Date
JP2002530420A true JP2002530420A (ja) 2002-09-17

Family

ID=22734935

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000583923A Pending JP2002530420A (ja) 1998-11-24 1999-11-23 平滑筋細胞増殖の阻害薬としてのベンジルマルトトリオシド

Country Status (7)

Country Link
EP (1) EP1133506A2 (zh)
JP (1) JP2002530420A (zh)
CN (1) CN1333778A (zh)
AU (1) AU1919800A (zh)
BR (1) BR9915643A (zh)
CA (1) CA2350759A1 (zh)
WO (1) WO2000031095A2 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115745A (en) * 1994-11-07 2000-11-21 American Home Prod Acylated benzylglycosides and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CN1333778A (zh) 2002-01-30
EP1133506A2 (en) 2001-09-19
BR9915643A (pt) 2001-08-07
WO2000031095A3 (en) 2001-01-04
WO2000031095A2 (en) 2000-06-02
AU1919800A (en) 2000-06-13
CA2350759A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
BR112020013198A2 (pt) inibidores heterobifuncionais de e-selectina e galectina-3
BR112021012482A2 (pt) C-glicosídeos inibidores de galectina-3
JPH1045805A (ja) 炭水化物誘導体
JP2002530420A (ja) 平滑筋細胞増殖の阻害薬としてのベンジルマルトトリオシド
US6451767B1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
US6291434B1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
JP2002530417A (ja) 平滑筋細胞増殖の阻害薬としてのベンジルラクトビオナミド
JP2002530424A (ja) 平滑筋細胞増殖の阻害薬としてのベンジルマルトシド
JP2002530418A (ja) 平滑筋細胞増殖の阻害薬としてのベンジルグリコシルアミド
JP2002531579A (ja) 平滑筋細胞増殖の阻害薬としてのアセチルベンジルマルトシド
MXPA01005172A (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
JP2002530419A (ja) 平滑筋細胞増殖の阻害薬としてのベンジルグリコシルアミド
US6187755B1 (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation
JP2003521460A (ja) 平滑筋細胞増殖の阻害薬としてのアセチル化ベンジルマルトシド
MXPA01005178A (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation
US7081448B2 (en) Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
JP2002530421A (ja) 平滑筋細胞増殖の阻害剤としてのアセタールベンジルマルトシド
US7132402B2 (en) Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6664243B1 (en) Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US6258784B1 (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
MXPA01005171A (es) Bencilglicosilamidas como inhibidores de la proliferacion de celulas de musculoliso
MXPA01005179A (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
WO1993018771A1 (fr) INHIBITEUR DE L'AGGLUTINATION PLAQUETTAIRE CONTENANT UN DERIVE DE STAUROSPORINE η-LACTAME
MXPA01005174A (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
MXPA01005173A (en) Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation